The CNS of the model organism Lymnaea stagnalis is relatively simple consisting of ~20,000 large identifiable neurons. This, together with the fact that the circuitry underlying complex behaviours such as feeding and respiration are well characterized make Lymnaea an attractive model to investigate the role of P2X receptors in CNS function. Methods RT-PCR with degenerate oligonucleotides was used to identify a P2X receptor fragment expressed in the Lymnaea CNS. The full length sequence was obtained by RACE-PCR and the cloned receptor was expressed in Xenopus oocytes to facilitate electrophysiological characterisation. Results ATP evokes inward currents at LymP2X with slow desensitisation and an EC 50 of 6.2 microM. BzATP is a partial agonist with a maximum response ~70% that of ATP and an EC 50 of 2.4 microM whereas alpha, beta-methylene ATP is a very weak agonist and ADP and UTP produce no response. Protons inhibit LymP2X with currents reduced by 55% at pH 6.5 compared to pH 7.5 with no change in EC 50 . Both PPADS and suramin are antagonists (IC 50 9.1 and 27.4 microM respectively). The divalent cations Cu 2+ and Zn 2+ have biphasic effects potentiating currents at concentrations up to 100 microM and inhibiting currents at 1mM. LymP2X is insensitive to ivermectin. Conclusion This work has increased our emerging phylogenetic knowledge of P2 receptors by adding molluscs to the list of organisms that possess functional P2X receptors. Knowledge of the pharmacological properties of LymP2X allows us now to probe the function of this receptor in vivo in the Lymnaea CNS.
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